At a glance
ClinicalIndex Comparison RecordN/ACompleted· 16 enrolled
Drug / intervention
Glutendietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Assessment of Immune Activation and Tolerance in Celiac Disease During Gluten Challenge
In Brief
A clinical study evaluating Gluten for Celiac Disease. Completed, enrolled 16 participants across 2 sites.
Detailed Summary
The primary purpose of this study is to characterize changes in gluten-specific T cells and pathology in the small intestine with specific focus on biomarkers likely to change with therapeutic celiac disease (CeD) treatment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCeliac Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedJan 2018
Enrollment StartApr 2018
Primary CompletionMay 2019
TodayJul 2026
First PostedJan 24, 2018
Enrollment StartApr 24, 2018
Primary CompletionMay 2, 2019
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 8.4 years ago
Interventions
Glutendietary
Gluten powder.